ProNAi Therapeutics Inc 4
4 · ProNAi Therapeutics Inc · Filed Jan 4, 2017
Insider Transaction Report
Form 4
Kowalski Mark
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy Class A Common Stock)
2017-01-03+300,000→ 300,000 totalExercise: $1.54Exp: 2027-01-03→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the total shares on January 3, 2018, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on January 3, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.